MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
123.41
+0.16
+0.13%
After Hours: 123.56 +0.15 +0.12% 19:58 12/05 EST
OPEN
123.77
PREV CLOSE
123.25
HIGH
124.18
LOW
122.69
VOLUME
7.52M
TURNOVER
--
52 WEEK HIGH
124.18
52 WEEK LOW
66.64
TOTAL ASSET
7.86B
YTD YIELD
26.84%
1D
5D
1M
3M
1Y
5Y
1D
Biotech ETF (XBI) Hits New 52-Week High
NASDAQ · 2d ago
More Changes at FDA Prompt Pushback From Former Leaders
Barron‘s · 3d ago
The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch.
Barron‘s · 3d ago
The Biotech Industry Is Healthier Than Investors -2-
Barron‘s · 3d ago
Turmoil at the FDA Threatens Biotech Recovery -- Heard on the Street
The Wall Street Journal · 3d ago
3 Potential Mid-Cap Biotech Buyout Targets In 2026
Seeking Alpha · 3d ago
SEC warns Direxion, ProShares, and Tidal, stalling new leveraged ETF launches
Seeking Alpha · 4d ago
SDOW Benefits, Risks And Leveraged ETF Watchlist
Seeking Alpha · 6d ago
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 TR USD
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider